导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.02% | 3051/4773 |
| 近一周 | -2.09% | 1201/5462 |
| 近一月 | -4.11% | 2222/5421 |
| 近一季 | -7.73% | 2513/5209 |
| 近半年 | -4.41% | 2513/4920 |
| 近一年 | -1.54% | 2891/4366 |
| 近两年 | 37.58% | 1993/2954 |
| 近三年 | 19.47% | 1485/2253 |
| 成立以来 | 74.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.63% 3320/4961 |
11.53% 2323/5312 |
- - |
- - |
| 2025 | 17.46% 2381/4813 |
-1.09% 2574/3635 |
1.39% 2357/4076 |
17.37% 2521/4524 |
-0.20% 2414/4813 |
| 2024 | 12.05% 1278/3463 |
2.06% 824/2808 |
-1.55% 1074/3014 |
13.98% 2064/3129 |
-2.16% 1976/3463 |
| 2023 | -10.43% 1304/2656 |
3.44% 1198/2280 |
-4.82% 1296/2385 |
-3.25% 880/2515 |
-5.97% 1578/2655 |
| 2022 | -18.85% 765/2207 |
-13.87% 858/1919 |
5.95% 805/2016 |
-12.05% 634/2113 |
1.11% 1382/2208 |
| 2021 | 7.38% 498/1822 |
-2.56% 667/1255 |
9.79% 521/1330 |
-1.82% 542/1466 |
2.24% 647/1822 |
| 2020 | 38.32% 363/1250 |
-6.95% 518/1028 |
15.48% 496/1067 |
13.35% 326/1164 |
13.56% 351/1184 |
| 2019 | 36.76% 351/1092 |
25.93% 435/754 |
-1.32% 305/804 |
1.73% 364/850 |
8.18% 341/918 |
| 2018 | - - |
- - |
- - |
- - |
-11.08% 248/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 平安MSCI中国A股ETF联接C VS. 长安沪深300非周期A(740101) |